A Clinical Trail to Study The Effect Of Siddha Drug Mithran Ambu Chooranam In Patients Having Urolithiasis(Vatha kalladaippu)

Phase II Non-randomized Open Clinical Evaluation Of Siddha drug Mithran ambu chooranam in Vatha Kalladaippu (Urolithiasis) -in Both Gender Age Between 18 to 60 Years patients Attending OPD at AAGHIM attached with GSMC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022249

Enrollment

Registered

2019-12-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N23- Unspecified renal colic

Interventions

Intervention1: Mithran ambu chooranam: 2.6 gm twice a day with palm jaggery for 10 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: presence of calculi in usg stone size 4 to 9 mm lower abdominal pain burning micturation oliguria dysurea haematuria

Exclusion criteria

Exclusion criteria: Stag horn calculus calculi associated with elevated serum creatinine level pregnancy hydronephrosis obstructive neuropathy

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatments.Timepoint: 10 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Asai Maniraja

Govt siddha medical college

nanbu.sumi@gmail.com8940838908

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026